30,432 Shares in Privia Health Group, Inc. $PRVA Bought by Moran Wealth Management LLC

Key Points

• Moran Wealth Management LLC purchased 30,432 shares of Privia Health Group, Inc. for approximately $700,000 in the second quarter.
• Institutional investors now own 94.48% of Privia Health Group's stock, indicating strong institutional confidence in the company.
• Privia Health Group reported a quarterly EPS of $0.10 and revenue of $213.61 million, with expectations for an annual EPS of $0.14.

Moran Wealth Management LLC bought a new position in Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor bought 30,432 shares of the company's stock, valued at approximately $700,000.

Other hedge funds also recently bought and sold shares of the company. Bessemer Group Inc. boosted its holdings in Privia Health Group by 2,393.4% in the 1st quarter. Bessemer Group Inc. now owns 2,269 shares of the company's stock worth $51,000 after buying an additional 2,178 shares during the period. Janney Montgomery Scott LLC boosted its holdings in Privia Health Group by 4.6% in the 1st quarter. Janney Montgomery Scott LLC now owns 55,371 shares of the company's stock worth $1,243,000 after buying an additional 2,413 shares during the period. GAMMA Investing LLC boosted its holdings in Privia Health Group by 113.1% in the 1st quarter. GAMMA Investing LLC now owns 2,866 shares of the company's stock worth $64,000 after buying an additional 1,521 shares during the period. Strs Ohio bought a new position in Privia Health Group in the 1st quarter worth $849,000. Finally, State of Alaska Department of Revenue boosted its holdings in Privia Health Group by 9.1% in the 2nd quarter. State of Alaska Department of Revenue now owns 62,406 shares of the company's stock worth $1,435,000 after buying an additional 5,223 shares during the period. Institutional investors own 94.48% of the company's stock.

Privia Health Group Trading Up 1.1%

Shares of NASDAQ:PRVA opened at $25.53 on Friday. Privia Health Group, Inc. has a 12 month low of $17.40 and a 12 month high of $26.09. The company has a 50-day moving average price of $22.89 and a 200 day moving average price of $22.52. The company has a market cap of $3.13 billion, a price-to-earnings ratio of 232.11, a PEG ratio of 3.44 and a beta of 0.83.

Privia Health Group (NASDAQ:PRVA - Get Free Report) last announced its quarterly earnings results on Tuesday, June 7th. The company reported $0.10 EPS for the quarter. Privia Health Group had a net margin of 0.78% and a return on equity of 2.13%. The firm had revenue of $213.61 million during the quarter. As a group, equities analysts forecast that Privia Health Group, Inc. will post 0.14 EPS for the current year.

Analyst Upgrades and Downgrades

PRVA has been the subject of several research reports. JMP Securities increased their price objective on shares of Privia Health Group from $29.00 to $30.00 and gave the company a "market outperform" rating in a report on Friday, August 29th. Piper Sandler dropped their price objective on shares of Privia Health Group from $36.00 to $35.00 and set an "overweight" rating for the company in a report on Monday, August 11th. Citigroup reissued an "outperform" rating on shares of Privia Health Group in a report on Friday, August 29th. Zacks Research raised shares of Privia Health Group from a "strong sell" rating to a "hold" rating in a report on Tuesday, August 19th. Finally, Barclays increased their price objective on shares of Privia Health Group from $21.00 to $22.00 and gave the company an "equal weight" rating in a report on Thursday, October 9th. Eleven equities research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, Privia Health Group has an average rating of "Moderate Buy" and a consensus price target of $28.91.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.

Want to see what other hedge funds are holding PRVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Privia Health Group, Inc. (NASDAQ:PRVA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.